Published in Respiratory Therapeutics Week, February 20th, 2006
Nigaard Pharma AS is a specialist respiratory pharmaceutical company based in Oslo, Norway and with offices in Sweden, Denmark and Finland. It has an existing network of contacts with pulmonary specialists and respiratory laboratories, which will be invaluable for developing the market for Aridol.
The 5-year agreement is effective immediately, and will capitalize on Pharmaxis' earlier Scandinavian marketing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week